ECT2 and neoplasm: Recent studies have shown that ECT2 can abnormally activate RhoA, and then the activated RhoA binds to ROCK, participating in the abnormal proliferation and migration of various tumor cells by mediating various cascade reactions (Zubor et al., 2020; Saito et al., 2004; Huff et al., 2013).